Navidea Biopharmaceuticals ROA 2010-2023 | NAVB
Current and historical return on assets (ROA) values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Navidea Biopharmaceuticals ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-09-30 | $0.00B | $0.01B | 0.00% |
| 2023-06-30 | $-0.01B | $0.01B | -120.00% |
| 2023-03-31 | $-0.02B | $0.00B | -400.00% |
| 2022-12-31 | $-0.02B | $0.00B | -400.00% |
| 2022-09-30 | $-0.02B | $0.01B | -360.00% |
| 2022-06-30 | $-0.01B | $0.00B | -208.70% |
| 2022-03-31 | $-0.01B | $0.00B | -154.84% |
| 2021-12-31 | $-0.01B | $0.01B | -129.73% |
| 2021-09-30 | $-0.01B | $0.01B | -115.79% |
| 2021-06-30 | $-0.01B | $0.01B | -137.14% |
| 2021-03-31 | $-0.01B | $0.01B | -141.94% |
| 2020-12-31 | $-0.01B | $0.01B | -176.00% |
| 2020-09-30 | $-0.01B | $0.01B | -209.52% |
| 2020-06-30 | $-0.01B | $0.01B | -220.00% |
| 2020-03-31 | $-0.01B | $0.00B | -228.57% |
| 2019-12-31 | $-0.01B | $0.00B | -200.00% |
| 2019-09-30 | $-0.01B | $0.01B | -176.00% |
| 2019-06-30 | $-0.01B | $0.01B | -165.52% |
| 2019-03-31 | $-0.01B | $0.01B | -146.67% |
| 2018-12-31 | $-0.02B | $0.01B | -148.84% |
| 2018-09-30 | $-0.02B | $0.01B | -119.30% |
| 2018-06-30 | $-0.01B | $0.01B | -78.87% |
| 2018-03-31 | $-0.02B | $0.02B | -77.27% |
| 2017-12-31 | $0.08B | $0.02B | 295.15% |
| 2017-09-30 | $0.08B | $0.02B | 323.40% |
| 2017-06-30 | $0.08B | $0.03B | 375.61% |
| 2017-03-31 | $0.08B | $0.03B | 461.54% |
| 2016-12-31 | $-0.02B | $0.01B | -136.36% |
| 2016-09-30 | $-0.01B | $0.01B | -119.15% |
| 2016-06-30 | $-0.02B | $0.01B | -166.04% |
| 2016-03-31 | $-0.03B | $0.01B | -151.52% |
| 2015-12-31 | $-0.03B | $0.02B | -172.31% |
| 2015-09-30 | $-0.03B | $0.02B | -206.45% |
| 2015-06-30 | $-0.03B | $0.02B | -196.83% |
| 2015-03-31 | $-0.03B | $0.01B | -190.77% |
| 2014-12-31 | $-0.04B | $0.01B | -165.52% |
| 2014-09-30 | $-0.04B | $0.02B | -149.57% |
| 2014-06-30 | $-0.05B | $0.02B | -127.89% |
| 2014-03-31 | $-0.05B | $0.03B | -122.08% |
| 2013-12-31 | $-0.04B | $0.04B | -124.44% |
| 2013-09-30 | $-0.04B | $0.05B | -130.84% |
| 2013-06-30 | $-0.03B | $0.03B | -185.92% |
| 2013-03-31 | $-0.03B | $0.01B | -193.33% |
| 2012-12-31 | $-0.03B | $0.01B | -163.38% |
| 2012-09-30 | $-0.03B | $0.01B | -133.33% |
| 2012-06-30 | $-0.00B | $0.02B | -3.67% |
| 2012-03-31 | $0.00B | $0.03B | 11.88% |
| 2011-12-31 | $0.01B | $0.03B | 26.67% |
| 2011-09-30 | $0.01B | $0.03B | 68.57% |
| 2011-06-30 | $-0.01B | $0.01B | -90.91% |
| 2011-03-31 | $-0.06B | $0.01B | -590.00% |
| 2010-12-31 | $-0.06B | $0.01B | -662.86% |
| 2010-09-30 | $-0.06B | $0.01B | -678.79% |
| 2010-06-30 | $-0.08B | $0.01B | -902.86% |
| 2010-03-31 | $-0.04B | $0.01B | -491.43% |
| 2009-12-31 | $-0.04B | $0.01B | -445.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.679B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $134.177B | 83.75 |
| Edwards Lifesciences (EW) | United States | $54.204B | 35.88 |
| DexCom (DXCM) | United States | $52.631B | 90.41 |
| IQVIA Holdings (IQV) | United States | $41.589B | 24.67 |
| IDEXX Laboratories (IDXX) | United States | $40.661B | 48.62 |
| Alcon (ALC) | Switzerland | $39.256B | 28.95 |
| STERIS (STE) | Ireland | $19.665B | 23.28 |
| Waters (WAT) | United States | $18.607B | 26.70 |
| Hologic (HOLX) | United States | $17.631B | 19.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.535B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.247B | 84.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $10.915B | 13.48 |
| Sysmex ADR (SSMXY) | Japan | $9.988B | 31.32 |
| Teleflex (TFX) | United States | $9.896B | 15.54 |
| Penumbra (PEN) | United States | $8.130B | 100.50 |
| Masimo (MASI) | United States | $7.312B | 41.00 |
| Globus Medical (GMED) | United States | $7.011B | 22.23 |
| Glaukos (GKOS) | United States | $4.796B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.997B | 25.55 |
| TransMedics (TMDX) | United States | $3.052B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.869B | 18.92 |
| Elekta AB (EKTAY) | Sweden | $2.673B | 18.34 |
| PROCEPT BioRobotics (PRCT) | United States | $2.650B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.501B | 10.27 |
| Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
| Inari Medical (NARI) | United States | $2.266B | 391.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.128B | 0.00 |
| RxSight (RXST) | United States | $2.009B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Veracyte (VCYT) | United States | $1.420B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.862B | 15.94 |
| OPKO Health (OPK) | United States | $0.843B | 0.00 |
| Artivion (AORT) | United States | $0.837B | 96.71 |
| Paragon 28 (FNA) | United States | $0.799B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.712B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.694B | 0.00 |
| SiBone (SIBN) | United States | $0.630B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.553B | 18.77 |
| IRadimed (IRMD) | United States | $0.520B | 30.17 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.493B | 0.00 |
| Nevro (NVRO) | United States | $0.466B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.430B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.375B | 0.00 |
| NeuroPace (NPCE) | United States | $0.369B | 0.00 |
| CVRx (CVRX) | United States | $0.354B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.342B | 11.50 |
| AxoGen (AXGN) | United States | $0.306B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.271B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.261B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.259B | 0.00 |
| Accuray (ARAY) | United States | $0.221B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.193B | 0.00 |
| 908 Devices (MASS) | United States | $0.191B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.190B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.183B | 9.84 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.120B | 0.00 |
| Envoy Medical (COCH) | United States | $0.117B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.057B | 10.32 |
| InspireMD (NSPR) | Israel | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 106.67 |
| Autonomix Medical (AMIX) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| LENSAR (LNSR) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |